Shopping Cart

Your shopping cart is currently empty

Proceed to checkout Continue shopping

(+)-(3R,8S)-Falcarindiol

Copy Product Info

😃Good

Catalog No. T5S1285Cas No. 225110-25-8

Alias Falcarindiol

1. (+)-(3R,8S)-Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis. 2. Falcarindiol induces immunosuppressive effects in vitro and in vivo and might be a novel therapy for autoimmune or allergic diseases. 3. Falcarindiol has protective effect against CCl(4) toxicity , in part, be explained by anti-lipid peroxidation activity associated with the induction of the GSTs including GSTA4.

(+)-(3R,8S)-Falcarindiol

Copy Product Info

😃Good

Purity: 97.06%

Catalog No. T5S1285Alias FalcarindiolCas No. 225110-25-8

Pack Size	Price	USA Warehouse	Global Warehouse
1 mg	$39	-	In Stock
5 mg	$123	In Stock	In Stock
10 mg	$197	-	In Stock
25 mg	$332	-	In Stock
50 mg	$496	-	In Stock
100 mg	$693	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:97.06%

Appearance:Liquid

Color:Yellow

Resource Download

COA HNMR HPLC

Product Introduction

(+)-(3R,8S)-Falcarindiol AI Summary

(+)-(3R,8S)-Falcarindiol exhibits a broad spectrum of bioactivity and cytotoxic properties. It demonstrates potent inhibitory activity against various cellular and enzymatic targets, including MK-I cells with an ED50 of 3.2 µg/mL in an MTT assay, and rat hepatocytes with an IC50 greater than 100,000 nM against D-GalN-induced cytotoxicity. Additionally, it inhibits LPS-induced NO production in mouse peritoneal macrophages with an IC50 of 4,400 nM. Acute toxicity in mice shows an LD50 greater than 200 mg/kg intraperitoneally. The compound also displays significant affinity and inhibition towards multiple opioid receptors: Ki values of 1125 nM for rat mu, 1096 nM for mouse delta, and 2515 nM for human kappa receptors, and an additional Ki value of 192 nM for displacing [3H]SCH-23390 from rat HA-tagged D1 dopamine receptors. It exhibits cytotoxic effects against human NCI60 cells with a GI50 of 660 nM, TGI of 2200 nM, and LC50 of 7600 nM, suggesting potential anticancer properties. In terms of enzymatic inhibition, (+)-(3R,8S)-Falcarindiol inhibits cyclooxygenase-1 (COX1) with an IC50 of 66,000 nM, and the enzyme PTP1B with an IC50 of 8.22 µg/mL. It also demonstrates inhibitory effects in toxicity assays with Artemia salina, with an LC50 of 3.32 µg/mL after 24 hours. Furthermore, the compound shows notable antimicrobial activity against various strains such as Escherichia coli, methicillin-resistant Staphylococcus aureus, Bacillus subtilis, and Candida albicans, with varying MIC values. It presents antituberculosis activity with a MIC of 6.2 µg/mL against Mycobacterium tuberculosis Erdman. Additionally, (+)-(3R,8S)-Falcarindiol modulates serotonergic pathways, specifically targeting the 5HT7 receptor, with an IC50 value of 117,500 nM and an inhibitory effect of 61.0% at 100 µM. (+)-(3R,8S)-Falcarindiol also affects melanogenesis in mouse B16 cells with an IC50 of 2.9 µg/mL, indicating potential applications in dermatology. It activates human PPARgamma in HEK293 cells, achieving a maximum fold activation of 3.26, with an EC50 of 3200 nM. Lastly, growth inhibition assays show activity against human MDA-MB-231 and BT-549 cells with TGI values of 6000 nM and 9000 nM, respectively, and exhibits selectivity for BT-549 cells..

Note: Summary generated by AI. Data source: ChEMBL

Bioactivity

Description	1. (+)-(3R,8S)-Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis. 2. Falcarindiol induces immunosuppressive effects in vitro and in vivo and might be a novel therapy for autoimmune or allergic diseases. 3. Falcarindiol has protective effect against CCl(4) toxicity , in part, be explained by anti-lipid peroxidation activity associated with the induction of the GSTs including GSTA4.
Targets&IC50	Mycobacterium tuberculosisH37Ra:6 μM (IC50)
Synonyms	Falcarindiol

Chemical Properties

Molecular Weight	260.37
Formula	C₁₇H₂₄O₂
Cas No.	225110-25-8
Smiles	CCCCCCC\C=C/[C@H](O)C#CC#C[C@H](O)C=C
Relative Density.	1.000 g/cm3 (Predicted)

Storage & Solubility Information

Storage

keep away from direct sunlight | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 2.5 mg/mL (9.6 mM), Sonication is recommended.

Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.68 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.8407 mL	19.2034 mL	38.4069 mL	192.0344 mL
5 mM	0.7681 mL	3.8407 mL	7.6814 mL	38.4069 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc